Robert Alexander Ingram, Director at OSI PHARMACEUTICALS INC (OSIP), sold 9,685 shares at $32.61 ($315K) on 2007-03-28, disclosed to the SEC on 2007-03-29.
Open-market sale of $315k OSIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.30 | 300 | $10K | 3.1% |
| 2 | $32.32 | 200 | $6K | 2.1% |
| 3 | $32.33 | 300 | $10K | 3.1% |
| 4 | $32.34 | 200 | $6K | 2.1% |
| 5 | $32.37 | 800 | $26K | 8.2% |
| 6 | $32.38 | 400 |
| $13K |
| 4.1% |
| 7 | $32.39 | 300 | $10K | 3.1% |
| 8 | $32.40 | 500 | $16K | 5.1% |
| 9 | $32.41 | 200 | $6K | 2.1% |
| 10 | $32.42 | 300 | $10K | 3.1% |
| 11 | $32.43 | 100 | $3K | 1.0% |
| 12 | $32.45 | 200 | $6K | 2.1% |
| 13 | $32.46 | 100 | $3K | 1.0% |
| 14 | $32.47 | 200 | $6K | 2.1% |
| 15 | $32.48 | 100 | $3K | 1.0% |
| 16 | $32.49 | 100 | $3K | 1.0% |
| 17 | $32.50 | 100 | $3K | 1.0% |
| 18 | $32.51 | 500 | $16K | 5.2% |
| 19 | $32.60 | 500 | $16K | 5.2% |
| 20 | $32.61 | 500 | $16K | 5.2% |
| 21 | $32.62 | 600 | $20K | 6.2% |
| 22 | $32.66 | 400 | $13K | 4.1% |
| 23 | $32.71 | 200 | $7K | 2.1% |
| 24 | $32.73 | 200 | $7K | 2.1% |
| 25 | $32.74 | 500 | $16K | 5.2% |
| 26 | $32.75 | 700 | $23K | 7.3% |
| 27 | $32.77 | 500 | $16K | 5.2% |
| 28 | $32.79 | 300 | $10K | 3.1% |
| 29 | $32.92 | 285 | $9K | 3.0% |
| 30 | $32.93 | 100 | $3K | 1.0% |
| Total | $32.55 avg | 9,685 | $315K | 100% |
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |